Primary Hepatitis A vaccination failure is a rare although possible event: results of a retrospective study

Vaccine

Volumn 24, Issue 35-36, 2006, Pages 6053-6057

  Bonanni, Paolo ^a   Bechini, Angela ^a   Pesavento, Giovanna ^a   Guadagno, Rosalba ^a   Santini, Maria Grazia ^b   Baretti, Simonetta ^b   Bartoloni, Alessandro ^a   Taliani, Gloria ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Local Health Agency   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Hepatitis A and B combination vaccine; Protection; Travel; Vaccine failure

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG STORAGE; DRUG TREATMENT FAILURE; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; MALE; PRIORITY JOURNAL; TRAVEL; VACCINATION;

CASE-CONTROL STUDIES; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; RETROSPECTIVE STUDIES;

EID: 33746829461     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.020     Document Type: Article

References (18)

1. Taliani G., Sbaragli S., Bartoloni A., Santini M.G., Tozzi A., and Paradisi F. Hepatitis A vaccine failure: how to treat the threat. Vaccine 21 31 (2003) 4505-4506
2. Franco E., Giambi C., Ialacci R., Coppola R.C., and Zanetti A.R. Risk groups for Hepatitis A virus infection. Vaccine 21 (2003) 2224-2233
3. Mele A., Stroffolini T., Palumbo F., et al., the SEIEVA Collaborating Group. Incidence of and risk factors for Hepatitis A in Italy: public health indications from a 10-year surveillance. J Hepatol 26 (1997) 743-747
4. Khuroo M.S. Viral hepatitis in international travellers: risks and prevention. Int J Antimicrob Agent 21 (2003) 143-152
5. Steffen R., Kane M.A., Shapiro C.N., Billo N., Schollhorn K.L., and Van Damme P. Epidemiology and prevention of Hepatitis A in travellers. JAMA 272 (1994) 885-889
6. WHO. Public health control of Hepatitis A: memorandum from a WHO meeting. Bull World Health Org 73 (1995) 15-20
7. Spira A.M. A review of combined Hepatitis A and Hepatitis B vaccination for travellers. Clin Ther 25 9 (2003) 2337-2351
8. Anonymous. FDA approval for a combined Hepatitis A and B vaccine. Notice to readers: FDA approval for a combined Hepatitis A and B vaccine. MMWR Morb Mortal Wkly Rep 50 37 (2001) 806-807
9. Van Damme P., and Van Herck K. A review of the efficacy, immunogenicity and tolerability of a combined Hepatitis A and B vaccine. Expert Rev Vaccines 3 3 (2004) 249-267
10. Van Damme P., Leroux-Roels G., Law B., Diaz-Mitoma F., Desombere I., Collard F., et al. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against Hepatitis A and B in children and adults. J Med Virol 65 1 (2001) 6-13
11. Ellliot J.H., Kunze M., and Torresi J. Hepatitis A vaccine failure. Lancet 359 (2002) 1948-1949
12. Junge U., Melching J., and Dziuba S. Acute Hepatitis A despite regular vaccination against Hepatitis A and B. Deut Med Wochenschr 127 30 (2002) 1581-1583
13. Ministero della Salute. http://www.ministerosalute.it/promozione/malattie/sezMalattie.jsp?label=inf.
14. Ciccozzi M., Tosti M.E., Gallo G., et al., the SEIEVA Collaborating Group. Risk of Hepatitis A infection following travel. J Viral Hepatitis 6 (2002) 460-465
15. Thoelen S., Van Damme P., Leentvaar-Kuypers A., Leroux-Roels G., Bruguera M., Frei P.C., et al. The first combined vaccine against Hepatitis A and B: an overview. Vaccine 17 13/14 (1999) 1657-1662
16. Averhoff F., Mahoney F., Coleman P., Schatz G., Hurwitz E., and Margolis H. Immunogenicity of Hepatitis B vaccines. Implications for persons at occupational risk of Hepatitis B virus infection. Am J Prev Med 15 1 (1998) 1-8
17. Floreani A., Baldo V., Cristofoletti M., Renzulli G., Valeri A., Zanetti C., et al. Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. Vaccine 22 5/6 (2004) 607-610
18. Wolters B., Junge U., Dziuba S., and Roggendorf M. Immunogenicity of combined Hepatitis A and B vaccine in elderly persons. Vaccine 21 25/26 (2003) 3623-3628